Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Carter

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Experimental Cell Research|March 5, 2011
Introduction to current and future protein therapeutics: a protein engineering perspectivePaul J Carter
Nature Reviews. Immunology|April 20, 2006
Potent antibody therapeutics by designPaul J Carter
Cell|July 22, 2022
Designing antibodies as therapeuticsPaul J Carter, Arvind Rajpal
Nature Reviews. Drug Discovery|October 18, 2024
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeuticsPaul J Carter, Valerie Quarmby
Nature Reviews. Drug Discovery|December 2, 2017
Next generation antibody drugs: pursuit of the 'high-hanging fruit'Paul J Carter, Greg A Lazar
Nature Reviews. Immunology|April 24, 2010
Therapeutic antibodies for autoimmunity and inflammationAndrew C Chan, Paul J Carter
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Antibody-drug conjugates for cancer therapyPaul J Carter, Peter D Senter
Molecular Immunology|February 1, 2015
Alternative molecular formats and therapeutic applications for bispecific antibodiesChristoph Spiess, Qianting Zhai, Paul J Carter
Current Opinion in Chemical Biology|May 21, 2013
Next generation therapeuticsPaul J Carter, Daria Hazuda, James A Wells
Nature Reviews. Immunology|August 7, 2025
Fifty years of monoclonals: the past, present and future of antibody therapeuticsAndrew C Chan, Greg D Martyn, Paul J Carter
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Experimental Cell Research|March 5, 2011
Introduction to current and future protein therapeutics: a protein engineering perspectivePaul J Carter
Nature Reviews. Immunology|April 20, 2006
Potent antibody therapeutics by designPaul J Carter
Cell|July 22, 2022
Designing antibodies as therapeuticsPaul J Carter, Arvind Rajpal
Nature Reviews. Drug Discovery|October 18, 2024
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeuticsPaul J Carter, Valerie Quarmby
Nature Reviews. Drug Discovery|December 2, 2017
Next generation antibody drugs: pursuit of the 'high-hanging fruit'Paul J Carter, Greg A Lazar
Nature Reviews. Immunology|April 24, 2010
Therapeutic antibodies for autoimmunity and inflammationAndrew C Chan, Paul J Carter
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Antibody-drug conjugates for cancer therapyPaul J Carter, Peter D Senter
Molecular Immunology|February 1, 2015
Alternative molecular formats and therapeutic applications for bispecific antibodiesChristoph Spiess, Qianting Zhai, Paul J Carter
Current Opinion in Chemical Biology|May 21, 2013
Next generation therapeuticsPaul J Carter, Daria Hazuda, James A Wells
Nature Reviews. Immunology|August 7, 2025
Fifty years of monoclonals: the past, present and future of antibody therapeuticsAndrew C Chan, Greg D Martyn, Paul J Carter
Pageof 4